<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03841916</url>
  </required_header>
  <id_info>
    <org_study_id>Body mass index</org_study_id>
    <nct_id>NCT03841916</nct_id>
  </id_info>
  <brief_title>Relation Between Body Mass Index and Endometrial Thickness</brief_title>
  <official_title>The Relationship Between Transvaginal Ultrasound Endometrial Thickness and Body Mass Index and Pathology in Postmenopausal Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aljazeera Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aljazeera Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postmenopausal Bleeding (PMB) is defined as recurrent attacks of bleeding occurring in women
      after menopause one year at least after stoppage of cycles [
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Premalignant lesions and malignant lesions most commonly complex hyperplasia with atypia and
      carcinoma of the endometrium are present in 1/3 of patients evaluated for postmenopausal
      bleed-ing, and so investigations for cases of postmeno-pausal bleeding are mandatory
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2, 2018</start_date>
  <completion_date type="Anticipated">March 20, 2019</completion_date>
  <primary_completion_date type="Actual">March 6, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the number of women who will have a relation between endometrial thickness and BMI</measure>
    <time_frame>within 2 weeks</time_frame>
    <description>if there is a relation between increased BMI and endometrial thickness</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Postmenopausal Bleeding</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>transvaginal ultrasound</intervention_name>
    <description>transvaginal ultrasound to measure endometrial thickness</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        women with postmenopausal bleeding
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  menopausal women (defined as minimum of 1 year of amenorrhea after the age of 45 years
             if only the amenorrhea is not related to pregnancy, medication or disease),

        Exclusion Criteria:

          -  Women with chronic diseases as diabetes mellitus, hypertension or hematological
             disorders, those received hormone replacement therapy, Tamoxifen or anticoagulant
             therapy and women with adnexal massed detected by TVUS or apparent causes of bleeding
             from cervix or vagina e.g. ulcer were excluded.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>women who have postmenopausal bleeding</gender_description>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Alalfy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud Alalfy, PhD</last_name>
    <phone>01002611058</phone>
    <email>mahmoudalalfy@ymail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Algazeerah and Kasralainy hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud Alalfy, master</last_name>
      <phone>+201002611058</phone>
      <email>mahmoudalalfy@ymail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ahmed Elgazzar, M.D</last_name>
      <phone>+201014005959</phone>
    </contact_backup>
    <investigator>
      <last_name>Mahmoud Alalfy, master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 12, 2019</study_first_submitted>
  <study_first_submitted_qc>February 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>March 8, 2019</last_update_submitted>
  <last_update_submitted_qc>March 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

